Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Presented for research literature review only Guthenberg C et al
Phase 3 trials are underway with potential approval in 2027
Understanding the reason for developing scurvy, whether this be social or medical, and addressing this will reduce the risk of recurrence
Reduced appetite and calorie intake Greater satiety after meals Less food-related preoccupation for some patients Improved glucose control in appropriate patients Weight reduction while treatment is continued Delayed stomach emptying matters beyond nausea It can affect oral-medicine absorption and may increase the risk of retained stomach contents during anesthesia or deep sedation
US$ 28.70
US$ 25.58
US$ 27.21
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 28.92
US$ 21.14
US$ 21.86
